Dominic Lenz

Country flagGermany

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Among genetic disorders of vesicular trafficking, there are three causing recurrent acute liver failure (RALF): NBAS, RINT1, and SCYL1‐associated disease. These three disorders are characterized by liver crises triggered by febrile infections and account for a relevant proportion of RALF causes. While the frequency and severity of liver crises in NBAS and RINT1‐associated disease decrease with age, patients with SCYL1 variants present with a progressive, cholestatic course. In all three diseases, there is a multisystemic, partially overlapping phenotype with variable expression, including liver, skeletal, and nervous systems, all organ systems with high secretory activity. There are no specific biomarkers for these diseases, and whole exome sequencing should be performed in patients with RALF of unknown etiology. NBAS, SCYL1, and RINT1 are involved in antegrade and retrograde vesicular trafficking. Pathomechanisms remain unclarified, but there is evidence of a decrease in concentration and stability of the protein primarily affected by the respective gene defect and its interaction partners, potentially causing impairment of vesicular transport. The impairment of protein secretion by compromised antegrade transport provides a possible explanation for different organ manifestations such as bone alteration due to lack of collagens or diabetes mellitus when insulin secretion is affected. Dysfunction of retrograde transport impairs membrane recycling and autophagy. The impairment of vesicular trafficking results in increased endoplasmic reticulum stress, which, in hepatocytes, can progress to hepatocytolysis. While there is no curative therapy, an early and consequent implementation of an emergency protocol seems crucial for optimal therapeutic management.

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (17)

Tian sun

Heidelberg University

GERMANY
View details

Michael Huber

Head Diagnostics and Development

University of Zurich

SWITZERLAND
View details

Sebastian Hiller

University of Basel

SWITZERLAND
View details

Georg-Friedrich Vogel

Medical University of Innsbruck

AUSTRIA
View details

Stefano Vavassori

Chief Operating Officer

metaLead Therapeutics AG

SWITZERLAND
View details

Chris Mühlhausen

Vice Director and Professor of Pediatrics

Universitätsmedizin Göttingen

GERMANY
View details

Erik Eklund

Associate professor, chief physician

Region Skåne

SWEDEN
View details

Barbara Brotschi

University Children's Hospital Zurich

SWITZERLAND
View details

Tayfun Güngör

University of Zurich

SWITZERLAND
View details

John Neidhardt

Full Prof.

University of Oldenburg

GERMANY
View details

Marcella Zollino

Università Cattolica del Sacro Cuore

ITALY
View details

Michael Gabbett

Queensland University of Technology

AUSTRALIA
View details

Mark Corbett

-

AUSTRALIA
View details

Adelheid Cerwenka

-

GERMANY
View details

Elodie M. Richard

-

FRANCE
View details

Philip Bufler

-

GERMANY
View details

Agnieszka Nadel

Institute of Human Genetics

POLAND
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.